These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7848325)

  • 21. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.
    Lewis JH
    J Rheumatol; 1997 Aug; 24(8):1459-60. PubMed ID: 9263133
    [No Abstract]   [Full Text] [Related]  

  • 22. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.
    Aponte J; Petrelli M
    Arthritis Rheum; 1988 Dec; 31(12):1457-64. PubMed ID: 3196364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines?
    Petrazzuoli M; Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM
    J Am Acad Dermatol; 1994 Dec; 31(6):969-77. PubMed ID: 7962779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: methotrexate in gastroenterology--dangerous villain or simply misunderstood?
    Tang H; Neuberger J
    Aliment Pharmacol Ther; 1996 Dec; 10(6):851-8. PubMed ID: 8971280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate and the liver.
    Tolman KG; Clegg DO; Lee RG; Ward JR
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():29-34. PubMed ID: 3831362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment with every-other-week methotrexate in rheumatoid arthritis patients with sustained disease improvement: comment on the article by Kremer et al.
    Roth SH
    Arthritis Rheum; 1995 Dec; 38(12):1865-6. PubMed ID: 8849365
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis.
    Bjorkman DJ; Hammond EH; Lee RG; Clegg DO; Tolman KG
    Arthritis Rheum; 1988 Dec; 31(12):1465-72. PubMed ID: 3196365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate therapy, rheumatoid arthritis, and life-threatening liver complications: should we be monitoring more closely?
    Tugnet N; Cooper SC; Douglas KM
    Scand J Rheumatol; 2012 Mar; 41(2):163-4. PubMed ID: 22420415
    [No Abstract]   [Full Text] [Related]  

  • 29. Not yet time to change the guidelines for monitoring methotrexate liver toxicity: they have served us well.
    Kremer JM
    J Rheumatol; 2002 Aug; 29(8):1590-2. PubMed ID: 12180714
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of patient population characteristics in assessing the efficacy and toxicity of methotrexate in rheumatoid arthritis: comment on the article by Weinblatt et al.
    Porter D; Capell H
    Arthritis Rheum; 1995 Aug; 38(8):1173-4. PubMed ID: 7639818
    [No Abstract]   [Full Text] [Related]  

  • 31. Methotrexate and lung disease in rheumatoid arthritis: comment on the article by Conway et al.
    Rojas-Serrano J; Mateos-Toledo H; Mejía M
    Arthritis Rheumatol; 2014 Sep; 66(9):2641-2. PubMed ID: 24909129
    [No Abstract]   [Full Text] [Related]  

  • 32. Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities.
    Yazici Y; Erkan D; Harrison MJ; Nikolov NP; Paget SA
    Clin Exp Rheumatol; 2005; 23(4):517-20. PubMed ID: 16095122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver disease, erroneously attributed to methotrexate, in a patient with rheumatoid arthritis.
    Bills LJ; Seibert D; Brick JE
    J Rheumatol; 1992 Dec; 19(12):1963-5. PubMed ID: 1294748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis.
    Kremer JM; Furst DE; Weinblatt ME; Blotner SD
    J Rheumatol; 1996 Mar; 23(3):459-61. PubMed ID: 8832983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
    Hall PD; Ahern MJ; Jarvis LR; Stoll P; Jenner MA; Harley H
    Ann Rheum Dis; 1991 Jul; 50(7):471-6. PubMed ID: 1877853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methotrexate in the treatment of rheumatoid arthritis].
    Korpela M
    Duodecim; 1996; 112(19):1830-5. PubMed ID: 10596184
    [No Abstract]   [Full Text] [Related]  

  • 37. Leucovorin versus folic acid in the treatment of methotrexate toxicity: comment on the article by Shiroky et al.
    Morgan SL; Baggott JE; Alarcón GS; Koopman WJ; Krumdieck CL
    Arthritis Rheum; 1994 Mar; 37(3):444-5. PubMed ID: 8155177
    [No Abstract]   [Full Text] [Related]  

  • 38. Methotrexate therapy in rheumatoid arthritis. Current status.
    Wilke WS; Mackenzie AH
    Drugs; 1986 Aug; 32(2):103-13. PubMed ID: 3743465
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study.
    Verstappen SM; Bakker MF; Heurkens AH; van der Veen MJ; Kruize AA; Geurts MA; Bijlsma JW; Jacobs JW;
    Ann Rheum Dis; 2010 Jun; 69(6):1044-8. PubMed ID: 19581281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate.
    Gupta R; Gupta SK
    MedGenMed; 2005 Sep; 7(3):9. PubMed ID: 16369235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.